Is erythropoietin a potential therapy for amyotrophic lateral sclerosis?

被引：4

作者：

Butsch, Patrick O. ^{[1
]}

Cudkowicz, Merit E. ^{[1
]}

机构：

[1] Neurol Clin Trials Univ, Dept Neurol, Charlestown, MA 02129 USA

来源：

EXPERIMENTAL NEUROLOGY | 2007年 / 206卷 / 01期

关键词：

D O I：

10.1016/j.expneurol.2007.04.001

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

页码：11 / 15

页数：5

共 64 条

[1] Variants in the ALS2 gene are not associated with sporadic amyotrophic lateral sclerosis [J].

Al-Chalabi, A ;

Hansen, VK ;

Simpson, CL ;

Xi, J ;

Hosler, BA ;

Powell, JF ;

McKenna-Yasek, D ;

Shaw, CE ;

Leigh, PN ;

Brown, RH .

NEUROGENETICS, 2003, 4 (04) :221-222

[2] Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease [J].

AlChalabi, A ;

Enayat, ZE ;

Bakker, MC ;

Sham, PC ;

Ball, DM ;

Shaw, CE ;

Lloyd, CM ;

Powell, JF ;

Leigh, PN .

LANCET, 1996, 347 (8995) :159-160

[3] Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells [J].

Beleslin-Cokic, BB ;

Cokic, VP ;

Yu, XB ;

Weksler, BB ;

Schechter, AN ;

Noguchi, CT .

BLOOD, 2004, 104 (07) :2073-2080

[4] Pure red-cell aplasia and epoetin therapy [J].

Bennett, CL ;

Luminari, S ;

Nissenson, AR ;

Tallman, MS ;

Klinge, SA ;

McWilliams, N ;

McKoy, JM ;

Kim, B ;

Lyons, EA ;

Trifilio, SM ;

Raisch, DW ;

Evens, AM ;

Kuzel, TM ;

Schumock, GT ;

Belknap, SM ;

Locatelli, F ;

Rossert, J ;

Casadevall, N .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (14) :1403-1408

[5] A CONTROLLED TRIAL OF RILUZOLE IN AMYOTROPHIC-LATERAL-SCLEROSIS [J].

BENSIMON, G ;

LACOMBLEZ, L ;

MEININGER, V ;

BOUCHE, P ;

DELWAIDE, C ;

COURATIER, P ;

BLIN, O ;

VIADER, F ;

PEYROSTPAUL, H ;

DAVID, J ;

MALOTEAUX, JM ;

HUGON, J ;

LATERRE, EC ;

RASCOL, A ;

CLANET, M ;

VALLAT, JM ;

DUMAS, A ;

SERRATRICE, G ;

LECHEVALLIER, B ;

PEUCH, AJ ;

NGUYEN, T ;

SHU, C ;

BASTIEN, P ;

PAPILLON, C ;

DURRLEMAN, S ;

LOUVEL, E ;

GUILLET, P ;

LEDOUX, L ;

ORVOENFRIJA, E ;

DIB, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (09) :585-591

[6] Erythropoietin in the cerebrospinal fluid in neurodegenerative diseases [J].

Brettschneider, Johannes ;

Widl, Karin ;

Ehrenreich, Hannelore ;

Riepe, Matthias ;

Tumani, Hayrettin .

NEUROSCIENCE LETTERS, 2006, 404 (03) :347-351

[7] Emerging biological roles for erythropoietin in the nervous system [J].

Brines, M ;

Cerami, A .

NATURE REVIEWS NEUROSCIENCE, 2005, 6 (06) :484-494

[8] Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor [J].

Brines, M ;

Grasso, G ;

Fiordaliso, F ;

Sfacteria, A ;

Ghezzi, P ;

Fratelli, M ;

Latini, R ;

Xie, QW ;

Smart, J ;

Su-Rick, CJ ;

Pobre, E ;

Diaz, D ;

Gomez, D ;

Hand, C ;

Coleman, T ;

Cerami, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (41) :14907-14912

[9] Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [J].

Brines, ML ;

Ghezzi, P ;

Keenan, S ;

Agnello, D ;

de Lanerolle, NC ;

Cerami, C ;

Itri, LM ;

Cerami, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10526-10531

[10] ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions [J].

Bruijn, LI ;

Becher, MW ;

Lee, MK ;

Anderson, KL ;

Jenkins, NA ;

Copeland, NG ;

Sisodia, SS ;

Rothstein, JD ;

Borchelt, DR ;

Price, DL ;

Cleveland, DW .

NEURON, 1997, 18 (02) :327-338

← 1 2 3 4 5 6 7 →